Filing Details
- Accession Number:
- 0000950170-25-086804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-16 16:48:09
- Reporting Period:
- 2025-06-12
- Filing Date:
- 2025-06-16
- Accepted Time:
- 2025-06-16 16:48:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658247 | Crinetics Pharmaceuticals Inc. | CRNX | Pharmaceutical Preparations (2834) | 263744114 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1886575 | F. Stephen Betz | C/O Crinetics Pharmaceuticals, Inc. 6055 Lusk Boulevard San Diego CA 92121 | Chief Scientific Officer | No | No | No | No |
Transaction Summary
| Sold: | 97,483 shares | Avg. Price: $32.23 | Total Value: $3,141,877.09 |
| Number of Shares After Transactions: | 99,713 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-12 | 71,525 | $1.91 | 180,551 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-06-12 | 16,645 | $9.28 | 197,196 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-12 | 97,483 | $32.23 | 99,713 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-06-12 | 71,525 | $0.00 | 71,525 | $1.91 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-06-12 | 16,645 | $0.00 | 16,645 | $9.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 108,514 | 2028-03-16 | No | 4 | M | Direct | |
| 58,198 | 2028-05-24 | No | 4 | M | Direct |
Footnotes
- Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan.
- The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $32.23 per share. The range of sales prices on the transaction date was $31.67 to $32.65 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request.
- The option vested in 48 equal monthly installments beginning on April 16, 2018.
- The option vested in 48 equal monthly installments beginning on June 25, 2018.
Billionaire Hedge Funds
